| Biologics, spondylitis and COVID-19 #MMPMID32522741Rosenbaum JT; Hamilton H; Choi D; Weisman MH; Reveille JD; Winthrop KLAnn Rheum Dis 2020[Dec]; 79 (12): 1663-1665 PMID32522741show ga
ä|Adrenal Cortex Hormones/*therapeutic use[MESH]|Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use[MESH]|Antirheumatic Agents/*therapeutic use[MESH]|Arthritis, Psoriatic/*drug therapy[MESH]|Betacoronavirus[MESH]|COVID-19[MESH]|Coronavirus Infections/*epidemiology/immunology[MESH]|Female[MESH]|Humans[MESH]|Janus Kinase Inhibitors/*therapeutic use[MESH]|Male[MESH]|Medication Adherence[MESH]|Middle Aged[MESH]|Pandemics[MESH]|Pneumonia, Viral/*epidemiology/immunology[MESH]|SARS-CoV-2[MESH]|Spondylarthropathies/drug therapy[MESH]|Spondylitis, Ankylosing/*drug therapy[MESH]|Surveys and Questionnaires[MESH]
DeepDyve Pubget Overpricing |
|